SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
31 hedge funds and large institutions have $56.7M invested in Sinovac Biotech, Ltd in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 9 closing their positions.
Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
9
Reduced
7
Closed
9
Calls
$776K
Puts
$265K
Net Calls
+$511K
Net Calls Change
+$547K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$21.2M |
2 |
NAH
2
Neumann Advisory (HK)
Central,
Hong Kong
|
$3.17M |
3 |
O
3
OrbiMed
New York
|
$22.4M |
4 |
SIM
4
Spark Investment Management
New York
|
$520K |
5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.93M |